Atlas Trials

Immunological Response to Intravesical BCG Therapy of Superficial Bladder Cancer by Prior Administration of RUTI®

Clinical trial NCT03191578 · COMPLETED

Trial details

NCT number
NCT03191578
Sponsor
Archivel Farma S.L.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
High-Risk Non-Muscle-Invasive Bladder Cancer
Start date
2017-06-16
Primary completion
2020-01-14
Enrollment
44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.